Aleksandar Beric, MD, Joins Spreemo as Senior Medical Advisor and Director of Neurophysiology

New York, NY (April 6, 2016) – Spreemo, a leading healthcare platform providing evidence-based quality metrics and predictive analytics to facilitate high-quality patient care, has named Aleksandar Beric, MD, as its Senior Medical Advisor and Director of Neurophysiology. Currently Director of Clinical Neurophysiology at NYU's Hospital for Joint Diseases, Dr. Beric will help oversee Spreemo’s clinical research and quality-focused efforts in neurophysiology and electrodiagnostic testing.

“Dr. Beric’s knowledge, experience and above all, passion for quality will prove invaluable to both our patients and payer-partners as we enhance our ability to deliver high-quality care across a wider range of disciplines,” said Ron Vianu, Spreemo’s CEO. “We are excited to welcome Dr. Beric aboard in order to improve upon and promote quality standards in neurophysiology, not only through the development of targeted quality metrics, but also through the creation of innovative educational programs for providers.”

“Spreemo’s mission to prioritize and champion quality care in medicine resonates deeply with me,” added Dr. Beric. “In my daily practice, I see firsthand the beneficial effect that high-quality electrodiagnostic testing can have on the trajectory of patient care. At the same time, I see tremendous opportunity for improvement on a broader scale. In that light, Spreemo provides the perfect collaborative environment to further develop quality initiatives around this testing through transparent dialogue with an engaged community of patients, payers and providers.”

In addition to his position as Director of Clinical Neurophysiology at NYU's Hospital for Joint Diseases, Dr. Beric serves as Professor of Neurology, Neurological Surgery, Orthopaedic Surgery and Rehabilitation at New York University. In his current roles, Dr. Beric runs one of the largest Neurology and Rehabilitation electromyography (“EMG”) training programs in the nation, where he is known for his rigor in ensuring that each of his residents graduates the program thoroughly prepared to deliver the highest quality care.

Spreemo, a leader in quality data analytics, is a rapidly growing healthcare platform that connects employers and insurers with the best providers in all 50 states. Spreemo’s platform enables the best treatment for occupational injuries, both improving outcomes and lowering the overall cost of care. Spreemo’s payer-partners are responsible for tens of millions of workers, including two of the three largest supermarket chains, two of the three largest pharmacy chains and several top 20 insurance carriers. To learn more, please visit www.spreemo.com.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.